ArdorComm Media Group

Tuesday, February 10, 2026 8:00 PM

Health & Wellness Community

Study in India Reveals Link Between Air Pollution and Type 2 Diabetes Risk

News on Health

Air pollution in India has been linked to an increased risk of type 2 diabetes, as revealed in a groundbreaking study published in the BMJ Open Diabetes Research and Care journal. The study, the first of its kind in India, was conducted in Delhi and Chennai, and it found that exposure to elevated levels of fine pollution particles (PM2.5) in the air, which are 30 times thinner than a strand of hair, is associated with higher blood sugar levels and an elevated incidence of type 2 diabetes. While the health impacts of fine particulate matter are known for cardiovascular and cardiometabolic diseases, this study sought to provide evidence from regions with high air pollution levels like India, where noncommunicable diseases are a significant burden. The research team, which included scientists from the Centre for Chronic Disease Control in New Delhi, followed a group of over 12,000 men and women from 2010 to 2017, regularly measuring their blood sugar levels. They also utilized satellite data and air pollution exposure models to assess air quality in the participants’ localities during that period. The results demonstrated that exposure to PM2.5 for just one month led to increased blood sugar levels, and prolonged exposure for a year or more elevated the risk of diabetes. Additionally, for every 10 micrograms per cubic meter (μg/m3) increase in the annual average PM2.5 levels in Delhi and Chennai, the risk of diabetes rose by 22 percent. The study addressed a significant research gap in South Asia, where diabetes is a major health concern, by providing robust exposure assessment and longitudinal data in this population. It underscores the need for tailored, population-specific policies to combat the high diabetes prevalence by reducing ambient air pollution. The research team, which also included scientists from the Public Health Foundation of India, Harvard University, Emory University, the All India Institute of Medical Sciences, and the Madras Diabetes Research Foundation, emphasized the importance of region-specific measures to achieve meaningful public health improvements at the population level.

Study in India Reveals Link Between Air Pollution and Type 2 Diabetes Risk Read More »

COVID Vaccination Doesn’t Increase Risk of Sudden Deaths Among Young Adults in India: Study

A study conducted by the Indian Council of Medical Research (ICMR) has found that COVID-19 vaccination does not raise the risk of sudden deaths among young adults in India. The research, titled “Factors associated with sudden deaths among adults aged 18-45 years in India,” is currently undergoing peer review and is yet to be published. The study’s findings indicate that factors such as previous hospitalization for COVID-19, binge drinking, and intense physical activity shortly before death are more likely to increase the risk of sudden deaths in this age group. Union Health Minister Mansukh Mandaviya, referencing the ICMR study, advised individuals who had experienced severe COVID-19 not to exert themselves excessively for a year or two to reduce the risk of heart attacks and cardiac arrests. The study was initiated due to concerns about anecdotal reports of sudden deaths among healthy young adults in India, potentially related to COVID-19 or vaccination. It analyzed cases of seemingly healthy individuals aged 18-45 who died suddenly from unexplained causes between October 1, 2021, and March 31, 2023. The research collected information on their medical history, behaviors, COVID-19 hospitalization, and vaccine doses administered, concluding that COVID-19 vaccination actually reduces the risk of sudden deaths among young adults in India. This study offers valuable insights into the factors contributing to such occurrences in this demographic.

COVID Vaccination Doesn’t Increase Risk of Sudden Deaths Among Young Adults in India: Study Read More »

Strides Pharma Sells Singapore Plant for $15M to Reduce Debt and Costs

Strides Pharma Science (Strides) has recently announced a significant development in its strategic restructuring efforts. The company has signed a binding agreement with Rxilient Biohub to sell its manufacturing facility in Singapore for a total of $15 million. The proceeds from this transaction will be allocated towards reducing the company’s debt. This sale also promises to yield substantial cost savings for Strides, with an annual reduction of INR 75 crore. Of this amount, INR 18 crore will be attributed to a decrease in operating expenses, while INR 57 crore will pertain to depreciation and operating lease expenses. It’s important to note that this transaction will not have any adverse impact on the company’s revenues and is expected to be earnings per share (EPS) accretive. The Singapore manufacturing facility had been inactive since the previous year as part of Strides’ broader strategy to optimize its manufacturing network and cut costs, which was unveiled as part of the FY23 reset strategy. Strides has been directing its efforts towards integrating its operations in the United States, and products previously supplied for US government procurement have already been transitioned to the Chestnut Ridge manufacturing site in the US. The company views this sale as the culmination of its ongoing manufacturing network optimization efforts, aligning with its core objectives of enhancing profitability and operational efficiency. The completion of this transaction is anticipated in the third quarter of FY24, contingent upon the receipt of necessary approvals.

Strides Pharma Sells Singapore Plant for $15M to Reduce Debt and Costs Read More »

WHO Calls for Regulation of AI in Healthcare Due to Risks, Citing Bias and Privacy Concerns

News on Health

The World Health Organization (WHO) is calling for the regulation of artificial intelligence (AI) in healthcare due to the associated risks, according to a report. WHO emphasizes the need to establish safety and efficacy in AI tools, make them accessible to those who require them, and encourage communication among AI developers and users. While recognizing AI’s potential to enhance healthcare by strengthening clinical trials, improving diagnosis and treatment, and enhancing healthcare professionals’ knowledge and skills, the report by data and analytics company GlobalData highlights the rapid deployment of AI technologies without a full understanding of their long-term implications, which could pose risks to healthcare professionals and patients. Alexandra Murdoch, a Senior Analyst at GlobalData, acknowledges the significant benefits of AI in healthcare but also highlights the risks associated with rapid adoption. AI systems in healthcare often have access to personal and medical information, necessitating regulatory frameworks to ensure privacy and security. Other challenges with AI in healthcare include unethical data collection, cybersecurity vulnerabilities, and the reinforcement of biases and dissemination of misinformation. An example of AI biases is found in a Stanford University study, which revealed that some AI chatbots provided inaccurate medical information about people of color. In this study, nine questions were posed to four AI chatbots, including OpenAI’s ChatGPT and Google’s Bard, and all four chatbots provided inaccurate information related to race and kidney and lung function. The use of such false medical information is a cause for concern, as it could lead to issues like misdiagnoses and improper treatment for patients of color. WHO has identified six areas for regulating AI in healthcare, with a focus on managing the risks associated with AI amplifying biases in training data. These areas for regulation include transparency and documentation, risk management, data validation and clarity of AI’s intended use, a commitment to data quality, privacy and data protection, and the promotion of collaboration. Alexandra Murdoch hopes that by outlining these regulatory areas, governments and regulatory bodies can develop regulations to safeguard healthcare professionals and patients while fully harnessing the potential of AI in healthcare.

WHO Calls for Regulation of AI in Healthcare Due to Risks, Citing Bias and Privacy Concerns Read More »

AI Early Detection System Prevents Strokes by Identifying Atrial Fibrillation

News on Health

Researchers have harnessed the power of artificial intelligence (AI) to identify irregular cardiac rhythms in individuals who have not yet exhibited symptoms. This AI system, which detected hidden signals in routine medical diagnostic tests, offers a promising avenue for doctors to proactively prevent strokes and other cardiovascular problems in individuals with atrial fibrillation, the most common type of heart rhythm disorder. While previous algorithms were predominantly tested on a narrow demographic, this new AI algorithm demonstrates effectiveness across various situations and patient populations, including veterans and underserved communities in the United States. The groundbreaking findings have been published in JAMA Cardiology, a reputable peer-reviewed journal. Dr. David Ouyang, a cardiologist at Cedars-Sinai’s Smidt Heart Institute and a researcher in the Division of Artificial Intelligence in Medicine, is the senior author of this study. He emphasizes the significance of this research in identifying concealed heart conditions and promoting the development of equitable and universally applicable algorithms for all patients. According to experts, approximately one in three people with atrial fibrillation remains undiagnosed. In this condition, the heart’s electrical signals, responsible for orchestrating the flow of blood from the upper chambers to the lower chambers, become chaotic. This can result in blood pooling in the upper chambers, leading to the formation of blood clots that may travel to the brain and trigger an ischemic stroke. The core of this groundbreaking discovery lies in an AI algorithm that was trained to recognize patterns within electrocardiogram (ECG) readings. ECG is a diagnostic test that monitors the heart’s electrical activity, typically involving the placement of electrodes on a patient’s body to capture these signals. By analyzing nearly one million ECGs, the AI model was not only able to accurately predict the onset of atrial fibrillation within 31 days but also demonstrated its effectiveness when applied to medical records of patients at Cedars-Sinai. Dr. Sumeet Chugh, the director of the Division of Artificial Intelligence in Medicine and the medical director of the Heart Rhythm Center at the Department of Cardiology, highlights the study’s geographic and ethnic diversity in its sample of veterans. This diversity underscores the potential of this algorithm to benefit a broad spectrum of the U.S. population. The research is a testament to the innovative ways in which AI is being harnessed at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine to proactively manage complex and challenging cardiac conditions.

AI Early Detection System Prevents Strokes by Identifying Atrial Fibrillation Read More »

Apollo Hospitals Opens Specialized Healthcare Hub in New Delhi for Premium Medical Services

News on Health

Apollo Health and Lifestyle Limited, a subsidiary of the Apollo Hospitals Group, has inaugurated a new specialized hospital in New Delhi. The grand opening ceremony was led by Dr. Sangita Reddy, the Joint Managing Director of the Apollo Hospitals Group. Dr. Reddy, accompanied by renowned actors Neha Dhupia and Angad Bedi, officiated the ribbon-cutting event for this premium hospital. This hospital, situated in Chirag Enclave, offers two distinct facilities: Apollo Spectra, which is India’s largest network of short-stay surgical centers, specializing in planned and day-care surgical services, and Apollo Cradle Royale, a luxurious dedicated facility for women’s health, maternity, childbirth, and paediatric care, ensuring comprehensive support for all their healthcare needs. Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, said, “At our Chirag Enclave facility, we bring together a world-class team of specialists, state-of-the-art technology, and a broad spectrum of services to cater to your unique healthcare needs. From cutting-edge surgical care to luxurious birthing options, gynaecology, fetal medicine, Level III NICU, e-NICU, advanced maternal diagnostics, 24*7 blood storage for high-risk pregnancy, dental spa, physiotherapy, audiometry, and pharmacy services, we cover your health journey comprehensively.” Operating as part of the Apollo Spectra Hospitals network, this advanced medical center offers a broad spectrum of services, including orthopedic and spinal care, general and minimally invasive surgery, ear, nose, and throat treatments, gastroenterology, weight loss surgery, urology, geriatric care, and various other medical specialties. It also serves as a comprehensive healthcare hub, offering preventive services, outpatient and inpatient care, medical management, and specialist consultations. The hospital specializes in cosmetic procedures like rhinoplasty and beauty-enhancement treatments, offers holistic weight loss programs that encompass both surgical and non-surgical options, and provides top-tier urological treatments for issues such as urethral problems and kidney stones. Furthermore, it excels in endoscopic spine surgery, hand, foot, and ankle surgeries, as well as the treatment of sports-related injuries. In the field of ear, nose, and throat care, it is well-prepared to handle complex cases, including cochlear implants, head and neck oncology, sinus-related issues, and surgeries related to sleep disorders, including laser-assisted procedures. To further enhance patient care, the hospital plans to introduce state-of-the-art robotic surgeries in the orthopedic field. It boasts modern medical facilities, including advanced operating theaters and an intensive care unit equipped with e-ICU or Tele ICU capabilities, facilitating seamless communication with the Apollo headquarters command center in Hyderabad.

Apollo Hospitals Opens Specialized Healthcare Hub in New Delhi for Premium Medical Services Read More »

AIIMS-Delhi Faces Patient Disruptions as Computer System Crashes

AIIMS encountered significant disruptions as its computer server experienced a crash, leading to extended delays for hundreds of patients seeking registration in the OPD and various hospital departments over two consecutive days. This marks the second instance of computer system failures at the hospital within a year. Officials, however, indicated that services were restored by Thursday afternoon, attributing the incident to maintenance work. Sources, on the other hand, suggested that the system malfunctioned following a software update. The breakdown had a severe impact on all patient services, including OPD registration, sample collection, report generation, billing, and admissions, resulting in substantial delays. Patients arriving at AIIMS for medical consultations had to endure extended waits as staff had to resort to manual registration due to the computer malfunction. One woman, for instance, who had come from Ghaziabad for a consultation in the medicine department, found herself waiting for over an hour without receiving a registration card. Staff members explained that the delay was a result of manual handling caused by the non-functioning computers. Existing patients at the institute, who required diagnostic tests, faced similar inconveniences. Long queues formed outside the smart lab as server issues prevented the generation of barcodes. The billing counters also encountered the same problems. The treatment process was delayed as lab reports were unavailable online, requiring patients to collect printouts. Additionally, the admission process was hindered, as the number of vacant beds wasn’t displayed online, according to sources. Since Wednesday morning, most administrative processes related to patient care have been conducted manually. A senior AIIMS doctor suggested that the administration should have a backup server system in place to ensure the institute’s smooth operation. While online systems offer convenience, they pose risks in the event of technical glitches. A manual system should be maintained for patient-related services, as complete reliance on online infrastructure could lead to system collapses, especially given AIIMS’s past experience with server hacks in November of the previous year. Some doctors expressed concerns that the institute’s data load may be overwhelming for the server to handle.

AIIMS-Delhi Faces Patient Disruptions as Computer System Crashes Read More »

India Leads Global Preterm Births in 2020, Lancet Study Reveals

In 2020, India witnessed the highest number of preterm births globally, with a staggering 3.02 million cases, constituting over 20 percent of all premature births worldwide, as revealed by a study published in The Lancet journal. This research, conducted by experts from the World Health Organization (WHO), the United Nations Children’s Fund (UNICEF), and the London School of Hygiene and Tropical Medicine, UK, further disclosed that more than half of all premature births in 2020 occurred in just eight countries. Following India, the countries with the highest preterm birth rates were Pakistan, Nigeria, China, Ethiopia, Bangladesh, the Democratic Republic of the Congo, and the United States, according to the researchers. The notable prevalence of preterm births in these regions is partly attributable to their substantial population sizes, high numbers of total births, and underdeveloped healthcare systems that struggle to provide high-quality family planning, antenatal care, and childbirth services to all those in need. Globally, approximately 13.4 million babies were born prematurely in 2020, with nearly one million succumbing to complications associated with preterm birth. This data equates to roughly one in ten babies being born prematurely, before completing 37 weeks of pregnancy worldwide. Given that prematurity ranks as the leading cause of child mortality in their early years, there is an urgent need to bolster both preterm infant care and preventative measures, particularly focusing on maternal health and nutrition to enhance child survival, emphasize the authors of the study. Furthermore, preterm birth significantly increases the likelihood of major illnesses, disabilities, developmental delays, and even chronic diseases like diabetes and heart conditions in adulthood for those who survive. This study derives its estimates from data that is representative of populations and national statistics, enabling internationally comparable assessments for the year 2020. It highlighted that India had the highest incidence of preterm births in 2020, totalling 3.02 million cases, accounting for over a fifth of all preterm births worldwide. While most high preterm birth rates were observed in low and middle-income nations, rates of 10 percent or higher were also evident in high-income countries such as Greece and the United States. Within South Asia, Bangladesh reported the highest preterm birth rate in 2020 at 16.2 percent, followed by Pakistan at 14.4 percent, and India at 13.0 percent. In Latin America, the rates ranged from 5.8 percent in Nicaragua to 12.8 percent in Suriname. As birth registration and facility-based deliveries have increased, data on the prevalence of preterm births has improved. Nevertheless, there are still 92 countries lacking sufficient nationally representative data. Consequently, the authors call for sustained efforts to enhance data availability, quality, and sharing to better target support and action where it is most needed. Dr. Anshu Banerjee, Director of Maternal, Newborn, Child, and Adolescent Health and Ageing at WHO, emphasized the vulnerability of preterm babies to life-threatening health complications and the necessity for dedicated care and attention. He stressed the urgency of substantial investments in services supporting preterm infants and their families, as well as a heightened focus on prevention, particularly ensuring access to quality healthcare before and during pregnancies. The researchers underscored that preterm birth is not exclusive to low and middle-income countries, as the data clearly reveals its impact on families worldwide, including some high-income countries such as Greece (11.6 percent) and the United States (10 percent).

India Leads Global Preterm Births in 2020, Lancet Study Reveals Read More »

High-Risk Medical Device Makers May Get License Extension

Manufacturers of high-risk medical devices, including ventilators, nebulizers, and x-ray equipment, may receive an extension to continue production due to a delay in the issuance of new regulatory licenses, according to a senior government official. The Central Drugs Standard Organisation (CDSCO) missed the October 1 deadline for issuing licenses, leading to the possibility of extensions for manufacturers who have already applied for licenses but have not received them yet. Those who have not yet applied for licenses will not be granted extensions. The October 1 deadline was set to bring ‘class C’ and ‘class D’ medical devices, which are considered ‘moderate’ and ‘high’ risk, under CDSCO regulation. This move was part of the government’s initiative to require certification by the drug regulator for all imported and locally manufactured medical devices before they can be sold in the country, ensuring quality standards are met. Manufacturers have reported that they applied for licenses in July but are still awaiting audits, which will determine whether they receive licenses. Medical devices are categorized based on the level of risk they present.

High-Risk Medical Device Makers May Get License Extension Read More »

Creatine Supplements Show Potential in Easing Long-Covid Symptoms

Creatine supplements have gained popularity in the fitness community for their perceived ability to enhance strength, power, and post-workout recovery. However, recent research has delved into the possibility of these supplements offering relief from certain long-Covid symptoms, particularly fatigue, shedding light on a potentially new application. So, what exactly are creatine supplements? Creatine is a natural compound found in muscle cells that aids in energy production during intense exercise, making it a favored supplement among gym-goers. In a study published in the journal Food Science & Nutrition, a team of researchers conducted a randomized controlled trial involving 12 individuals recently diagnosed with long Covid. This robust study design aimed to assess the effectiveness of creatine supplementation. Participants were divided into two groups, with one receiving a daily creatine supplement and the other a placebo cleverly disguised as inulin, a dietary fiber. Both substances were identical white powders mixed into water, ensuring a double-blind trial where neither participants nor researchers knew who received creatine until the study’s conclusion. The six-month trial allowed ample time for creatine to potentially exert its effects. Multiple measures were assessed, including self-reported fatigue levels, improvements in various long Covid symptoms, endurance during physical activity (an objective measure of fatigue), and creatine levels in muscle and brain tissues. While the creatine group did exhibit higher creatine concentrations in tissues after six months, there were no significant differences in fatigue levels between the two groups. However, creatine showed promise in alleviating other long Covid symptoms, such as improvements in loss of smell and taste, breathing difficulties, body aches, headaches, and concentration issues. It’s important to note that this study represents the first exploration of creatine’s potential in treating long Covid symptoms. Nonetheless, creatine’s known safety profile, minimal side effects, affordability, and ease of use make it an intriguing avenue for further research in the limited treatment landscape for long Covid.

Creatine Supplements Show Potential in Easing Long-Covid Symptoms Read More »